Karuna Therapeutics Inc (NASDAQ:KRTX)
| 126.23 Delayed Data As of Jul 01 |  -0.28 / -0.22%Today’s Change | 92.26 Today|||52-Week Range 161.98 | -3.64% Year-to-Date |
Latest KRTX News | Press Releases
No recent news for Karuna Therapeutics Inc.
Today’s Trading
| Previous close | 126.51 |
| Today’s open | 126.58 |
| Day’s range | 116.72 - 127.88 |
| Volume | 25,539 |
| Average volume (3 months) | 260,575 |
| Market cap | $3.5B |
Data as of 3:59pm ET, 07/01/2022
Growth & Valuation
| Earnings growth (last year) | -90.39% |
| Earnings growth (this year) | -62.35% |
| Earnings growth (next 5 years) | -18.16% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 103.27 |
| Price/Book | 6.93 |
Competitors
Data as of 3:59pm ET, 07/01/2022
Financials
| Next reporting date | August 4, 2022 |
| EPS forecast (this quarter) | -$2.07 |
| Annual revenue (last year) | $37.0M |
| Annual profit (last year) | -$143.8M |
| Net profit margin | -389.04% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
